Optimizing anticoagulation for patients receiving Impella support-Reference-Cited by-同舟云学术

Optimizing anticoagulation for patients receiving Impella support

Published:2021-11 Issue:11 Volume:41 Page:932-942
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Beavers Craig J.¹^ORCID,DiDomenico Robert J.²^ORCID,Dunn Steven P.³^ORCID,Cox Jenna⁴,To Long⁵,Weeks Phillip⁶^ORCID,Trujillo Toby C.⁷,Jennings Douglas L.⁸⁹^ORCID

Affiliation:

1. University of Kentucky College of Pharmacy Lexington Kentucky USA

2. Department of Pharmacy Practice University of Illinois Chicago College of Pharmacy Chicago Illinois USA

3. Department of Pharmacy University of Virginia Heart and Vascular Center Charlottesville Virginia USA

4. Department of Pharmacy Prisma Health Richland Hospital Columbia South Carolina USA

5. Department of Pharmacy Henry Ford Health System Detroit Michigan USA

6. Department of Pharmacy Memorial Hermann Health System Houston Texas USA

7. University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences/University of Colorado Hospital Denver Colorado USA

8. Arnold & Marie Schwartz College of Pharmacy and Health Sciences Department of Pharmacy Practice Long Island University New York New York USA

9. Department of Pharmacy New York‐Presbyterian Hospital Columbia University Medical Center New York New York USA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2629

Reference61 articles.

1. Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST‐Elevation Myocardial Infarction in the United States

2. Ten‐Year (2001–2011) Trends in the Incidence Rates and Short‐Term Outcomes of Early Versus Late Onset Cardiogenic Shock After Hospitalization for Acute Myocardial Infarction

3. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association;Diepen S;Circulation,2017

4. Cardiogenic shock during heart failure hospitalizations: Age-, sex-, and race-stratified trends in incidence and outcomes

5. The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pragmatic approach to temporary mechanical circulatory support in acute right ventricular failure;The Journal of Heart and Lung Transplantation;2024-07

2. Usefulness of bicarbonate-based Impella purge solution in a patient with heparin-induced thrombocytopenia: the first case report of long-term management in Japan;Journal of Artificial Organs;2024-06-06

3. Short-term use of an Impella ventricular assist device sterile water–based bicarbonate purge solution for positron emission tomography scanning;American Journal of Health-System Pharmacy;2024-06-03

4. Mechanical Circulatory Support in Cardiogenic Shock;Cardiology Clinics;2024-05

5. Perioperative Left Ventricular Assist Device Use in Patients With Reduced Ejection Fraction Reduces Cardiac Surgery-Associated Acute Kidney Injury;Cureus;2024-03-30